Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
Bradley Maron, Editor-in-Chief of Circulation at American Heart Association, shared a post on LinkedIn about a recent article by Jake Silberg, published in Circulation, adding:
”This Week in Circulation:
This week’s feature on agentic and generative AI in drug discovery is already generating real conversation — including from the authors themselves.
Dr. James Zou and colleagues discuss how AI is changing therapeutic development. They break down a complicated topic into clear terms — extremely exciting, and extremely relevant to cardiovascular medicine.
The piece walks through how AI is starting to reshape three key stages of cardiovascular drug development: target selection, therapeutic design, and clinical trial recruitment. Congratulations to Jake Silberg, Peter Eckmann, Joseph Boen, and James Zou on a piece that’s clearly striking a nerve with the field.
Here’s why it matters: the tools are early, and the authors are candid about that — but the direction of travel is one every translational scientist should be watching.”
Title: Agentic and Generative AI for Drug Discovery
Authors: Jake Silberg, Peter Eckmann, Joseph Boen, James Zou
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring
-
Aug 11, 2026, 14:30Bharat Moyal: The New KDIGO 2026 Approach to Anemia in CKD